Listed by the USPTO as BECKHARDT, LYNDSEY MARIE
Tech Center 3700 • Art Units: 1613 1615 1621 1674 3783
This examiner grants 28% of resolved cases
Lyndsey Marie Beckhardt works in tech center 3700 and art unit 1613. Her record covers 571 resolved cases, with an allowance rate of 27.8% and a median of 1457 days to allowance. The interview lift is 48.0%, indicating a strong association between interviews and improved allowance outcomes despite the low allowance rate.
The leading companies are L'Oréal, The Regents of the University of Michigan, and Henkel AG & Co. KGaA. The leading firms are Knobbe, Martens, Olson & Bear, LLP, OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P., and AMIN, TUROCY & WATSON, LLP. Practitioners may treat interview preparation as a central prosecution tool, supported by precise amendments and arguments. The median timing also supports early assessment of risk, budget, and portfolio strategy.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18199939 | DELIVERY DEVICES AND METHODS FOR MAKING THE SAME | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 18099810 | DELIVERY DEVICES AND METHODS FOR MAKING THE SAME | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 19242592 | INJECTABLE BIOPOLYMER COMPOSITIONS AND ASSOCIATED SYSTEMS AND METHODS | Final Rejection | Covidien LP |
| 18327140 | POWDER FOR ACHIEVING HEMOSTASIS | Final Rejection | Boston Scientific Scimed, Inc. |
| 18727765 | SKIN MICROBIOME FRIENDLY SUNSCREENS | Non-Final OA | BASF SE |
| 17904553 | CROSSLINKED POLY(LACTIDE-CO-GLYCOLIDE) (PLGA)-DIMETHACRYLATE COATINGS AND METHODS OF USE | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18157371 | ANTI-FOULING IMPLANTABLE MATERIAL AND METHOD OF MAKING | Non-Final OA | Edwards Lifesciences Corporation |
| 18017583 | COMPOSITION FOR PREVENTING ADHESION | Non-Final OA | The University of Tokyo |
| 18044233 | PHARMACEUTICAL COMPOSITION COMPRISING CHLOROQUINE AND USES THEREOF | Non-Final OA | Philip Morris Products S.A. |
| 17916215 | NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF | Final Rejection | CORNELL UNIVERSITY |
| 18727872 | Antibacterial Resin and Molded Body Comprising Same | Final Rejection | LG Chem, Ltd. |
| 18719492 | METHOD FOR PURIFYING COMPOSITION | Non-Final OA | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY |
| 17915430 | Zinc-Containing Medical Instrument | Non-Final OA | BIOTYX MEDICAL (SHENZHEN) CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy27.8% of resolved applications examined by Lyndsey Marie Beckhardt were allowed (571 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.
This examiner's interview lift is +48.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Lyndsey Marie Beckhardt took 1,457 days on average from filing to allowance.
Lyndsey Marie Beckhardt examines applications in Art Unit 1613 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
